FTSE 100 8,412.60 ▲ +0.55% FTSE 250 20,884.20 ▲ +0.31% GBP/USD 1.2718 ▼ -0.14% GBP/EUR 1.1842 ▲ +0.09% BRENT $78.40 ▲ +0.62% GOLD $2,614 ▼ -0.08% BoE RATE 4.75% ▲ 0.00 BTC $104,220 ▲ +1.24% FTSE 100 8,412.60 ▲ +0.55% FTSE 250 20,884.20 ▲ +0.31% GBP/USD 1.2718 ▼ -0.14% GBP/EUR 1.1842 ▲ +0.09% BRENT $78.40 ▲ +0.62% GOLD $2,614 ▼ -0.08% BoE RATE 4.75% ▲ 0.00 BTC $104,220 ▲ +1.24%
Wednesday, September 9, 2026 · London
UK business, markets & policy
Business

Orexin discovers awarded prestigious Lasker award

A new FDA CBER head, AI company Schrodinger with a new startup, and more biotech news from The Readout Adobe Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging…

Orexin discovers awarded prestigious Lasker award

A new FDA CBER head, AI company Schrodinger with a new startup, and more biotech news from The Readout Adobe Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter , and co-hosts STAT’s weekly biotech podcast, The Readout Loud . You can reach Elaine on Signal at elaineywchen.70.

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “ The Readout Loud .” You can reach Allison on Signal at AllisonDeAngelis.01. Want to stay on top of the science and politics driving biotech today?

Sign up to get our biotech newsletter in your inbox. First came the new teaser for Nathan Fielder’s documentary on Elizabeth Holmes. Now come the memes.

Bring it on. FDA names permanent heads of drug and biologics centers For the past few months, key centers at the FDA have been led by acting officials. The agency said yesterday it will now make them permanent.

Michael Davis will be director of the Center for Drug Evaluation and Research, and Karim Mikhail will be director of the Center for Biologics Evaluation and Research. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe National Biotech Reporter Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector.

She co-writes The Readout newsletter , and co-hosts STAT’s weekly biotech podcast, The Readout Loud . You can reach Elaine on Signal at elaineywchen.70. Biotech Startups and Venture Capital Reporter Allison covers what hot startups are getting up to, and who’s financing them.

She is also co-host of the weekly biotech podcast, “ The Readout Loud .” You can reach Allison on Signal at AllisonDeAngelis.01.

Source: STAT

Distributed to UK News Post by RedPress.

Related News

Contact Advertise Search RSS